Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Rewriting Life

Industrial-Strength Algae

To you, it might be green pond scum. But to some researchers, algae is a vehicle for making key pharmaceutical and industrial compounds. A recent patent could give one company a virtual corner on the biotech algae market. The patent, issued to Martek Biosciences of Columbia, Md., outlines a process to grow non-algal genes in algal cells. The process takes place in a few hours, in contrast to the months it takes to introduce genes into transgenic crop plants like corn or tobacco. The process could also help model the large-scale production of chemicals in crops in fast-growing algae. Martek is working on algal production methods for docosahexaenoic acid, a baby formula ingredient that aids mental development.

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Basic.
  • Insider Basic {! insider.prices.basic !}*

    {! insider.display.menuOptionsLabel !}

    Six issues of our award winning print magazine, unlimited online access plus The Download with the top tech stories delivered daily to your inbox.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Bimonthly print magazine (6 issues per year)

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.